Patent Yard Sign in
Canadian application, no grantCanada

Novel recombinant xylanase, the production and use thereof

CA 2262989 A1 · Owner: Chuang, Ming-Hon · Inventors: Chang, Edward L.; Lin, Lung-Shen; Jeng, King-Song

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides a genetically recombinant xylanase with high yield and good activity, and a process for the production of the recombinant xylanase. The present invention also provides the coding sequence of the recombinant sequence, vectors bearing the coding sequence and the transformants containing the vectors. The present invention further provide a column wherein the recombinant xylanase is immobilized.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 4, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 4, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 4, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 4, 1999
GrantedNo grant recorded
Term endedMarch 4, 2019
Patent numberCA 2262989 A1
Classification (IPC)C12N15/56 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedMarch 4, 1999Term endedMarch 4, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.